Top Markets
Coin of the day
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Kedudukan dalam Saham #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Harga Saham
$0.46
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$3.42M
Perubahan (1 hari)
3.60%
Perubahan (1 tahun)
-34.54%
Negara
US
Perdagangan Pasithea Therapeutics Corp. (KTTA)

Kategori

Harga KTTA dengan permodalan pasaran b
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
KTTA
$0.46
Modal pasaran bagi Pasithea Therapeutics Corp.(KTTA)
Modal Pasaran: $3.42M
Sehingga August 2026, Pasithea Therapeutics Corp. mempunyai modal pasaran sebanyak $3.42M. Ini menjadikan Pasithea Therapeutics Corp. syarikat ke-35798th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Pasithea Therapeutics Corp. dari 2021 hingga 2026
KTTA berbanding dengan 5 teratas yang paling popular stocks
Harga KTTA Aset B Pasaran B Hasilnya
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$732,538 $3.42M
$5.452T +159,247,394.66%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$603,300 $3.42M
$4.490T +131,152,102.86%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$559,280 $3.42M
$4.162T +121,582,616.58%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$493,971 $3.42M
$3.676T +107,384,809.47%
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.
$380,661 $3.42M
$2.833T +82,752,263.50%